Philip L. Grover
- Cancer Research top 1%
- Molecular Biology top 5%
- Health, Toxicology and Mutagenesis top 1%
- Pharmacology top 0.5%
- Organic Chemistry top 5%
- Co-authors
- Peter SimsDavid H. PhillipsAlan HewerColin S. CooperEliezer HubermanCharles HeidelbergerHans MarquardtToshio Kuroki
- Topics
- Carcinogens and Genotoxicity Assessment (38 papers)Effects and risks of endocrine disrupting chemicals (17 papers)Toxic Organic Pollutants Impact (10 papers)
- Journals
- Proceedings of the National Academy of SciencesBiochemical and Biophysical Research CommunicationsFEBS Letters
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Philip L. Grover
76 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 125
- Cancer Research 1.6k
- Molecular Biology 1.4k
- Health, Toxicology and Mutagenesis 788
- Pharmacology 492
- Organic Chemistry 460
Countries citing papers authored by Philip L. Grover
This map shows the geographic impact of Philip L. Grover's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip L. Grover with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip L. Grover more than expected).
Fields of papers citing papers by Philip L. Grover
This network shows the impact of papers produced by Philip L. Grover. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip L. Grover. The network helps show where Philip L. Grover may publish in the future.
Co-authorship network of co-authors of Philip L. Grover
This figure shows the co-authorship network connecting the top 25 collaborators of Philip L. Grover. A scholar is included among the top collaborators of Philip L. Grover based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip L. Grover. Philip L. Grover is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 2 | |
| 3 | 2 | |
| 4 | 24 | |
| 5 | 26 | |
| 6 | Genotoxicity of human mammary lipid. | 44 |
| 7 | 87 | |
| 8 | 8 | |
| 9 | 33 | |
| 10 | 22 | |
| 11 | 44 | |
| 12 | 49 | |
| 13 | 14 | |
| 14 | 8 | |
| 15 | 7 | |
| 16 | 14 | |
| 17 | 4 | |
| 18 | Chemical carcinogens and DNA | 213 |
| 19 | 27 | |
| 20 | 155 |
About Philip L. Grover
Philip L. Grover is a scholar working on Cancer Research, Health, Toxicology and Mutagenesis and Pharmacology, having authored 76 papers that have together received 3.0k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (38 papers), Effects and risks of endocrine disrupting chemicals (17 papers) and Toxic Organic Pollutants Impact (10 papers). The work is most often cited by research in Cancer Research (1.6k citations), Health, Toxicology and Mutagenesis (788 citations) and Pharmacology (492 citations). Philip L. Grover has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Peter Sims, David H. Phillips, Alan Hewer, Colin S. Cooper, Eliezer Huberman, Charles Heidelberger, Hans Marquardt, Toshio Kuroki, James K. Selkirk and Brian Tierney. Their work appears in journals such as Proceedings of the National Academy of Sciences, Biochemical and Biophysical Research Communications and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.